Further evidence in support of the activator role played by PRMT5 comes from studies of the Fibroblast-derived Growth Factor Receptor-3 (FGFR-3) and eukaryotic elongation Initiation Factor-4E (eIF4E) genes in colorectal cancer [25]. Here, PRMT5 is linked to colorectal cancer.